These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18528298)

  • 1. Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machine.
    Schallmach E; Sareli R; Besser MJ; Leipsiger S; Hardan I; Treves AJ; Nagler A; Schachter J
    J Immunother; 2008; 31(6):563-8. PubMed ID: 18528298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.
    Schmitt A; Reinhardt P; Hus I; Tabarkiewicz J; Roliñski J; Barth T; Giannopoulos K; Dmoszyñska A; Wiesneth M; Schmitt M
    Transfusion; 2007 Sep; 47(9):1588-94. PubMed ID: 17725721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity.
    Tran CA; Burton L; Russom D; Wagner JR; Jensen MC; Forman SJ; DiGiusto DL
    J Immunother; 2007 Sep; 30(6):644-54. PubMed ID: 17667528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
    Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
    Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
    Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
    Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program.
    Powell DJ; Brennan AL; Zheng Z; Huynh H; Cotte J; Levine BL
    Cytotherapy; 2009; 11(7):923-35. PubMed ID: 19903104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients.
    Faradji A; Bohbot A; Schmitt-Goguel M; Siffert JC; Dumont S; Wiesel ML; Piemont Y; Eischen A; Bergerat JP; Bartholeyns J
    J Immunol Methods; 1994 Sep; 174(1-2):297-309. PubMed ID: 8083534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte enriched apheresis for preparation of dendritic cells (DC) to be used in cellular therapy.
    Svensson A; Adamson L; Pisa P; Petersson M; Hansson M
    Transfus Apher Sci; 2005 Oct; 33(2):165-73. PubMed ID: 16129662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
    Van Driessche A; Van de Velde AL; Nijs G; Braeckman T; Stein B; De Vries JM; Berneman ZN; Van Tendeloo VF
    Cytotherapy; 2009; 11(5):653-68. PubMed ID: 19530029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
    Sumida Y; Nakamura K; Kanayama K; Akiho H; Teshima T; Takayanagi R
    Cytotherapy; 2008; 10(7):698-710. PubMed ID: 18985477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: product quality and prediction of the yield using different harvest procedures.
    Wolf CE; Meyer M; Riggert J
    Vox Sang; 2005 May; 88(4):249-55. PubMed ID: 15877646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.
    Peres E; Wood GW; Poulik J; Baynes R; Sood S; Abidi MH; Klein J; Bhambhani K; Dansey R; Abella E
    Neuropediatrics; 2008 Jun; 39(3):151-6. PubMed ID: 18991194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
    Mueller K; Schweier O; Pircher H
    Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.
    Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H
    Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy.
    Skitzki JJ; Muhitch JB; Evans SS
    Immunol Invest; 2007; 36(5-6):807-27. PubMed ID: 18161530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity.
    Micklethwaite KP; Garvin FM; Kariotis MR; Yee LL; Hansen AM; Antonenas V; Sartor MM; Turtle CJ; Gottlieb DJ
    Cytotherapy; 2009; 11(2):218-28. PubMed ID: 19242837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Cobe AutoPBSC and Gambro Elutra as a platform for monocyte enrichment in dendritic cell (DC) therapy: clinical study.
    Chen Y; Hoecker P; Zeng J; Dettke M
    J Clin Apher; 2008; 23(5):157-62. PubMed ID: 18712854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.